SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-018861
Filing Date
2020-04-27
Accepted
2020-04-27 16:54:36
Documents
6
Period of Report
2020-06-24
Effectiveness Date
2020-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A arpo-def14a_20200624.htm DEF 14A 1046000
2 GRAPHIC gvdfqqo0kc0o000004.jpg GRAPHIC 91807
3 GRAPHIC gvdfqqo0kc0o000001.jpg GRAPHIC 2927
4 GRAPHIC gvdfqqo0kc0o000005.jpg GRAPHIC 41618
5 GRAPHIC gvdfqqo0kc0o000003.jpg GRAPHIC 67070
6 GRAPHIC gvdfqqo0kc0o000002.jpg GRAPHIC 4440
  Complete submission text file 0001564590-20-018861.txt   1334116
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38560 | Film No.: 20820868
SIC: 2834 Pharmaceutical Preparations